Addressing Discrimination and Mistrust Among Black Men: Phase III
26 janvier 2016 mis à jour par: Laura Bogart, Boston Children's Hospital
The purpose of this research study is to test a group program aimed at improving the quality of life of HIV+ Black men who have sex with men.
The group will address ways to cope with discrimination and will help men examine mistrust that they may have about healthcare, including doctors and other healthcare providers and HIV medications.
The aim is to provide a supportive community for HIV+ Black men.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
The aim of the study is to examine whether the pilot intervention can reduce mistrust and improve coping responses to discrimination among HIV positive Black men who have sex with men (MSM).
We will conduct a small randomized pilot trial to test the feasibility of evaluation methods.
All participants will attend a baseline, a first follow-up visit, and a final follow-up visit (each 3 months apart) at which they will take computer assessments.
Participants who are assigned to the intervention will attend 9 weekly intervention sessions after baseline and before the first follow-up.
Using a wait-list control design, control group participants from the first two cohorts will be offered the intervention after they complete the final follow-up visit.
Control group participants from the third cohort will be offered the intervention after they complete the first final-up visit and before they complete their final follow-up due to timing and budgetary restraints.
We will hold three consecutive groups for our small randomized control trial.
This means that we will be recruiting continuously; once we finish recruiting for the first group, we will start recruiting for the second group, and so on.
Each group has about 12 or 13 intervention and 7-11 control participants.
Type d'étude
Interventionnel
Inscription (Réel)
64
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02215
- Fenway Health
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Homme
La description
Inclusion Criteria:
- 18 years-old or older
- Biologically male at birth
- Currently self-identifies as male
- Self-identifies as Black or African American (mixed-race individuals will be eligible if they primarily identify as Black or African American)
- HIV-positive
- Reported having sex with men in lifetime
- Able and willing to provide informed consent
Exclusion Criteria:
- Does not meet all of the inclusion criteria (e.g., if they are unable to provide proof of their HIV-positive status)
- Unable to provide informed consent
- Reports or presents evidence of severe mental health problems that require immediate treatment (e.g., psychotic symptoms, active suicidality at time of enrollment) or diagnosed mental disorder that would limit the ability to participate (e.g., dementia)
- Reports or presents evidence of cognitive impairments that limit the ability to comprehend the informed consent or to fully participate in the various parts of the study (assessments, intervention, homework).
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Intervention Group
Participants will attend the baseline, first follow-up, and final follow-up study visits, at which they take computer surveys.
After their baseline interview and before their first follow-up interview, participants attend the Intervention Group, which consist of 9 weekly group sessions.
Each of the weekly sessions is led by a mental health professional and a peer facilitator who uses Cognitive Behavioral Therapy techniques to work with participants in tracking their cognitions, emotions, and behaviors in response to stressful/discrimination experiences.
|
Participants attend 9 weekly group sessions.
Each of the weekly sessions is led by a mental health professional and a peer facilitator who use Cognitive Behavioral Therapy techniques to work with participants in tracking their cognitions, emotions and behaviors in response to stressful/discrimination experiences.
|
|
Aucune intervention: Waitlist Control
Participants are not given the Intervention Group while they are enrolled in the study. Instead, they only attend the baseline, first follow-up, and final follow-up study visits, at which they take computer surveys. After they have completed the study, participants from the first two cohorts are offered the option of attending an intervention group that is identical in content to the intervention group being studied.The third cohort is offered the intervention group after they have completed the first follow-up but before they complete the final follow-up due to timing and budgetary restraints. No data is collected and no incentives are given during these intervention groups. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Coping
Délai: 3 months post-baseline
|
Improved coping scores on Brief Cope, Emotional and Behavioral Coping, and Africultural Coping scales
|
3 months post-baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Mistrust
Délai: 3 months post-baseline
|
Reduced mistrust scores on Medical Mistrust scale
|
3 months post-baseline
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Laura M Bogart, PhD, Boston Children's Hospital
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 juillet 2014
Achèvement primaire (Réel)
1 octobre 2015
Achèvement de l'étude (Réel)
1 décembre 2015
Dates d'inscription aux études
Première soumission
12 août 2014
Première soumission répondant aux critères de contrôle qualité
20 août 2014
Première publication (Estimation)
22 août 2014
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
28 janvier 2016
Dernière mise à jour soumise répondant aux critères de contrôle qualité
26 janvier 2016
Dernière vérification
1 janvier 2016
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- IRB-P00002878
- R34MH096544-03 (Subvention/contrat des NIH des États-Unis)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .